🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareRetatrutide anticipation thread — what are your questions for Phase 3? Page 5

Retatrutide anticipation thread — what are your questions for Phase 3?

rick_sfbay Mon, Mar 23, 2026 at 11:14 PM 32 replies 903 viewsPage 5 of 7
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Apr 3, 2026 at 11:31 PM#21

A narrower follow-up, since the general answer is now clear:

How to read a result like this without either dismissing it or over-reading it, since the summaries all read like press releases?

1 24SarahChen_PharmD
Reply Quote Save Share Report
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Apr 8, 2026 at 6:42 AM#22
Dr.EndoEP said:
Read four things before the headline number.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

2 0MikeNYC_runner
Reply Quote Save Share Report
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Apr 12, 2026 at 1:51 PM#23
Dr.EndoEP said:
Read four things before the headline number.

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

Last edited: Apr 12, 2026 at 2:51 PM
3 1PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Apr 16, 2026 at 8:58 PM#24
Dr.EndoEP said:
Read four things before the headline number.

Saving this. It is the first explanation that did not require me to already understand it.

4 2Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 1 other
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Apr 21, 2026 at 4:02 AM#25

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

5 3Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 2 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register